• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF; OXYGENTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF; OXYGENTOR Back to Search Results
Catalog Number CX*FX25RW
Device Problem Hole In Material (1293)
Patient Problem No Patient Involvement (2645)
Event Date 09/07/2015
Event Type  malfunction  
Manufacturer Narrative
This section was completed by the manufacturer per cfr 803.52(f) (11) because the information was not initially completed by the user facility.The actual device has not been received by the manufacturing facility for evaluation.A follow up report will be submitted within 30 days from the date that this report was sent.For this reason code was used in the conclusions section.A review of the device history record and product release decision control sheet of the involved product/lot# combination confirmed there were no indications of production-related anomalies.A search of the complaint file found no report with the involved product code/lot# combination.(b)(4).All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.Actual device not returned.
 
Event Description
The user facility reported a hole in the polycarbonate housing of the oxygenator.Follow up communication with the user facility reported the following information: (1) the reported hole was noted to be surrounded by blackened material; and (2) there was not patient involvement.
 
Manufacturer Narrative
This report is being submitted as follow-up no.2 for mfg.Report no.9681834-2015-00205 to provide the return sample evaluation results.The actual sample was returned to the manufacturing facility for evaluation.Visual inspection was conducted and was noted to meet manufacturing specifications.The actual sample was built into a circuit with a roller pump and tubes and the circuit was circulated with saline solution at the flow rate of approx.5.0l/min.No leak was confirmed.The actual sample was filled with saline solution and pressurized at approx.2.0kgf/cm2.No leak was observed.The actual sample was disassembled for further inspection of the air bubble.No presence of a foreign substance was found adhering inside the bubble.A review of the device history record and product release decision control sheet of the involved product code lot # combination confirmed that there no production related problems.A search of the complaint file found no previous reports of this nature with the involved product code lot # combination.The exact cause of the reported event cannot be determined based upon the available information.The evaluation results verified that the actual sample was of normal product.There are many complex clinical variables that may have affected the reportedly observed conditions during the procedure.However, there is no indication that the reported event was related to a product malfunction or defect.All currently available information has been placed on file by qa at the manufacturing facility for appropriate tracking, trending, and follow up.(b)(4).
 
Event Description
This report is being submitted as follow-up no.2 for mfg.Report no.9681834-2015-00205 to provide the return sample evaluation results.
 
Manufacturer Narrative
As stated, this report is being submitted as follow-up no.1 for mfg.Report no.9681834-2015-00205.The actual device was returned to the manufacturing facility and the evaluation is currently ongoing.A follow up report will be submitted when the investigation is complete, but no later than 30 days from the date that this report was sent.For this reason (b)(4) was used in the conclusions section.All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.
 
Event Description
This report is being submitted as follow-up no.1 for mfg.Report no.9681834-2015-00205.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF
Type of Device
OXYGENTOR
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key5123057
MDR Text Key27298797
Report Number9681834-2015-00205
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Followup,Followup
Report Date 09/08/2015,10/02/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2018
Device Catalogue NumberCX*FX25RW
Device Lot Number150413
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/23/2015
Is the Reporter a Health Professional? No
Distributor Facility Aware Date09/07/2015
Device Age5 MO
Event Location Hospital
Date Report to Manufacturer09/08/2015
Date Manufacturer Received10/23/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-